He has served as a consultant to the Pan American Health Organization and WHO on issues of vaccine evaluation, and has received substantial National Institutes of Health funding for statistical research on vaccine evaluation. He has been the principal statistician on many large vaccine, HIV, and nutritional intervention trials. His two decades of experience in the public health arena have given him the broad perspective necessary for the judicious interpretation of data in numerous contexts. Both the director and co-director have served on numerous data and safety monitoring boards for vaccine studies. The executive committee is made up of the IVS director and co-director and coordinators of the key areas of Institute activity.
Coordinators serve for two-year, renewable terms at the discretion of the director.
Board members will recommend issues for the Institute to pursue and provide feedback and assessment regarding the specific activities undertaken by the Institute. A Scientific Advisory Board will be appointed to provide expert advice on specific vaccine safety issues. Recognized experts in vaccine evaluation and safety, ethics, and risk assessment from institutions throughout the country including agencies such as CDC, NIH and the Vaccine Injury Compensation Program will be called upon to assist in the development of Institute reviews. The Institute seeks financial support for core activities in the form of unrestricted grants from foundations, federal agencies, legal groups, and product manufacturers. Endowments are sought to support core activities and fees are charged for specific services such as specialized literature searches, interpretation of scientific data, publications, and reviews of individual cases of possible vaccine injury.